Search research articles
Contact Us
Filters
Showing results (911-920 of 1,180) with videos related to
Page
of 118
Sort By:
Prostate Cancer and Prostatic Diseases
|
May 25, 2016
Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-up
D E Spratt, W C Jackson, A Abugharib, et al.
Multiple Sclerosis and Related Disorders
|
December 6, 2021
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels
I M Vavasour, P Becquart, J Gill, et al.
NPJ Genomic Medicine
|
September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT Signatures
Nicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2000
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
I Cokgor, G Akabani, C T Kuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2021
Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance
Rana R McKay, Lucia Kwak, Jett P Crowdis, et al.
Investigational New Drugs
|
March 3, 2026
Phase I multi-center clinical and biomarker study of the dual-action androgen receptor inhibitor ONCT-534
Matthew R Chrostek, James Robinson, Rajesh Krishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results
D D Bigner, M T Brown, A H Friedman, et al.
BJU International
|
March 25, 2016
Independent surgical validation of the new prostate cancer grade-grouping system
Daniel E Spratt, Adam I Cole, Ganesh S Palapattu, et al.
Prostate Cancer and Prostatic Diseases
|
March 31, 2025
Racial variation in the advanced prostate cancer genome
Emily M Feng, Jenny Vo-Phamhi, Aishwarya N Subramanian, et al.
Prostate Cancer and Prostatic Diseases
|
November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B Benzon, S G Zhao, M C Haffner, et al.
Page
of 118
Search research articles
Search
Showing results (911-920 of 1,180) with videos related to
Sort By:
Page
of 118
Prostate Cancer and Prostatic Diseases
|
May 25, 2016
Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-up
D E Spratt, W C Jackson, A Abugharib, et al.
Multiple Sclerosis and Related Disorders
|
December 6, 2021
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels
I M Vavasour, P Becquart, J Gill, et al.
NPJ Genomic Medicine
|
September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT Signatures
Nicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2000
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
I Cokgor, G Akabani, C T Kuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2021
Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance
Rana R McKay, Lucia Kwak, Jett P Crowdis, et al.
Investigational New Drugs
|
March 3, 2026
Phase I multi-center clinical and biomarker study of the dual-action androgen receptor inhibitor ONCT-534
Matthew R Chrostek, James Robinson, Rajesh Krishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results
D D Bigner, M T Brown, A H Friedman, et al.
BJU International
|
March 25, 2016
Independent surgical validation of the new prostate cancer grade-grouping system
Daniel E Spratt, Adam I Cole, Ganesh S Palapattu, et al.
Prostate Cancer and Prostatic Diseases
|
March 31, 2025
Racial variation in the advanced prostate cancer genome
Emily M Feng, Jenny Vo-Phamhi, Aishwarya N Subramanian, et al.
Prostate Cancer and Prostatic Diseases
|
November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B Benzon, S G Zhao, M C Haffner, et al.
Page
of 118